Actively Recruiting
Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.
Led by University of Edinburgh · Updated on 2025-09-15
118
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Some patients who come to the emergency department with chest pain and have not had a heart attack, are at an increased risk of having a heart attack in the future. The investigators know this by taking a blood test (troponin) which looks at damage to the patient's heart. These patients are often sent home from hospital with no information about their risk of heart disease. A patient survey revealed that patients in the emergency department would like to receive more information about heart disease. In this study the investigators will provide patients who are at increased risk of cardiovascular disease with their troponin value. The investigators will deliver this information within a cardiovascular brief intervention, which is a short conversation with a patient about their health. In a previous study the investigators carried out some interviews with patients to find out how their results should be delivered and what information should be included in a cardiovascular brief intervention. The investigators also asked them the best way to provide patients with this information. The aim of this part of the study it to determine if the new cardiovascular brief intervention helps patients understand their risk and if it results in them making changes to their health.
CONDITIONS
Official Title
Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who present to the Emergency Department with symptoms suggestive of acute coronary syndrome
- A maximum high-sensitivity cardiac troponin I between 5 ng/L and the sex-specific 99th centile
- Resides in Scotland and has a CHI number
- Adults aged 18 and over
- No history of cardiovascular disease
- At least 1 modifiable cardiovascular risk factor: current smoker, hypertension (140/90 mmHg), hypercholesterolaemia (>6.0 mmol/L), overweight and obesity (BMI >25), hyperglycaemia or diabetes mellitus
- Patients who are able to provide informed consent
You will not qualify if you...
- Patients with a diagnosis of acute coronary syndrome during index presentation
- Patients who are not able to give informed consent
- Patients who do not speak English
- Patients who are unable to attend hospital as outpatient to receive the cardiovascular brief intervention
- Patients with ongoing or planned cardiovascular investigations or interventions
- Patients with chronic kidney disease and a eGFR below 30 ml/min
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NHS Lothian
Edinburgh, United Kingdom
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here